Barclays PLC Boosts Stock Holdings in Mirion Technologies, Inc. (NYSE:MIR)

Barclays PLC grew its position in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 14.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 353,322 shares of the company's stock after acquiring an additional 45,642 shares during the quarter. Barclays PLC owned 0.15% of Mirion Technologies worth $6,166,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Mirion Technologies by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 23,909,802 shares of the company's stock worth $417,226,000 after buying an additional 227,178 shares during the period. Geode Capital Management LLC grew its holdings in shares of Mirion Technologies by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 4,571,828 shares of the company's stock valued at $79,796,000 after purchasing an additional 69,373 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Mirion Technologies by 29,948.6% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,214,921 shares of the company's stock worth $73,550,000 after purchasing an additional 4,200,894 shares in the last quarter. William Blair Investment Management LLC acquired a new position in Mirion Technologies during the 4th quarter worth approximately $53,066,000. Finally, Artemis Investment Management LLP acquired a new position in Mirion Technologies during the 4th quarter worth approximately $38,155,000. Institutional investors and hedge funds own 78.51% of the company's stock.

Mirion Technologies Stock Up 0.5 %

Shares of Mirion Technologies stock traded up $0.08 during trading hours on Monday, reaching $15.40. The company's stock had a trading volume of 1,612,469 shares, compared to its average volume of 1,679,080. Mirion Technologies, Inc. has a one year low of $9.11 and a one year high of $18.81. The company has a market capitalization of $3.58 billion, a P/E ratio of -81.05 and a beta of 0.75. The stock's fifty day simple moving average is $14.53 and its two-hundred day simple moving average is $15.62. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16.

Mirion Technologies (NYSE:MIR - Get Free Report) last released its quarterly earnings results on Tuesday, February 11th. The company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. On average, research analysts forecast that Mirion Technologies, Inc. will post 0.39 earnings per share for the current year.

Wall Street Analyst Weigh In

MIR has been the subject of several recent research reports. B. Riley decreased their price target on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, April 16th. Robert W. Baird decreased their price objective on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. Finally, Citigroup cut their target price on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $18.75.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.